Phoenix NP announced a continued rise in patient satisfaction across Arizona, noting that positive feedback has increased as more women seek safe, FDA-approved GLP-1 weight loss medications through ...

Weight loss drug Ozempic was launched in India on Friday, with 0.25mg doses priced at $24.35 a week. Pharmaceutical company ...

If you visit a fast-food chain in the next few years, expect the menu to look a little less gluttonous. In between the usual deep-fried options, industry observers anticipate more offerings that come ...

This article highlights the impact of diabetes on the community, with 13% of adults in Florence County living with the ...

Medicare will pay an average of 36 percent less for 15 of its most expensive prescription drugs starting in 2027, the U.S. health plan said ...

For a limited time, patients can get a steep discount on the popular medications, as long as they’re paying out of pocket Steve Christo/Corbis/Corbis/Getty Ozempic ...

The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ...

Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without insurance. The drugmaker said Monday that it has started selling higher doses ...

The previous price for Wegovy without insurance was $499. The cash price for popular weight-loss medications Wegovy and Ozempic is dropping by 30% in the U.S. on Monday, according to Novo Nordisk, the ...

Novo Nordisk (NVO) has cut the price of its weight-loss injection Wegovy by as much as 37% from its launch price in India, as the Danish drugmaker plays catch-up with rival Eli Lilly (LLY), whose ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels.

Hims & Hers Health (HIMS) traded ~6% higher on Tuesday after the telehealth platform, with its Q3 2025 results, said it is in "active discussions" with Novo Nordisk (NVO) to sell the Danish ...